CanBridge Pharma
北海康成
CanBridge Pharma
Biotech/Healthcare
CanBridge Pharma is a Chinese Biotech/Healthcare company. Latest round: Post-IPO (2025).
Latest round: Post-IPO (2025)
Source: ChinaBulls — chinabulls.com
Last updated 2025-08-01
Funding history
Request access to view this section.
Investors
Request access to view this section.
HQ & website
Request access to view this section.
Tags
Request access to view this section.